A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC
PHASE2
This is a single-arm, open-label Phase IIa study designed to evaluate the e...
Status
Recruiting
Location
MengChao Hepatobiliary Hospital of Fujian Medical University